Issue 19, 2013

Gold amides as anticancer drugs: synthesis and activity studies

Abstract

Modular gold amide chemotherapeutics: Access to modern chemotherapeutics with robust and flexible synthetic routes that are amenable to extensive customisation is a key requirement in drug synthesis and discovery. A class of chiral gold amide complexes featuring amino acid derived ligands is reported herein. They all exhibit in vitro cytotoxicity against two slow growing breast cancer cell lines with limited toxicity towards normal epithelial cells.

Graphical abstract: Gold amides as anticancer drugs: synthesis and activity studies

Supplementary files

Article information

Article type
Paper
Submitted
19 Dec 2012
Accepted
26 Mar 2013
First published
15 Apr 2013

Org. Biomol. Chem., 2013,11, 3255-3260

Gold amides as anticancer drugs: synthesis and activity studies

S. Newcombe, M. Bobin, A. Shrikhande, C. Gallop, Y. Pace, H. Yong, R. Gates, S. Chaudhuri, M. Roe, E. Hoffmann and E. M. E. Viseux, Org. Biomol. Chem., 2013, 11, 3255 DOI: 10.1039/C3OB27460H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements